BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34614087)

  • 1. Incidence of acute radiodermatitis in women with breast cancer undergoing hypofractionated radiotherapy.
    Martelletti LBSJ; Aguiar BRL; Vieira LAC; Menêses AG; Bontempo PSM; Ferreira EB; Reis PEDD
    Rev Bras Enferm; 2021; 75(1):e20210118. PubMed ID: 34614087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of radiodermatitis in breast cancer patients during hypofractionated radiotherapy.
    Vieira LAC; Menêses AG; Bontempo PSM; Simino GPR; Ferreira EB; Guerra ENDS; Reis PEDD
    Rev Esc Enferm USP; 2022; 56():e20220173. PubMed ID: 36469486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute radiodermatitis in cancer patients: incidence and severity estimates.
    Bontempo PSM; Ciol MA; Menêses AG; Simino GPR; Ferreira EB; Reis PEDD
    Rev Esc Enferm USP; 2021; 55():e03676. PubMed ID: 33886907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of radiodermatitis and factors associated with its severity in women with breast cancer: a cohort study.
    Cavalcante LG; Domingues RAR; Junior BO; Fernandes MAR; Pessoa EC; Abbade LPF
    An Bras Dermatol; 2024; 99(1):57-65. PubMed ID: 37657957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
    Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
    Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Skin Microbiome Dynamics With Radiodermatitis in Patients With Breast Cancer.
    Hülpüsch C; Neumann AU; Reiger M; Fischer JC; de Tomassi A; Hammel G; Gülzow C; Fleming M; Dapper H; Mayinger M; Vogel M; Ertl C; Combs SE; Traidl-Hoffmann C; Borm KJ
    JAMA Oncol; 2024 Apr; 10(4):516-521. PubMed ID: 38300584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal trends in skin-related and global quality of life among women with breast radiodermatitis: A pilot study.
    Beamer LC; Grant M
    Eur J Oncol Nurs; 2018 Apr; 33():22-27. PubMed ID: 29551173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors of acute radiodermatitis in breast cancer after adjuvant radiotherapy treated with RT3D or IMRT].
    Thomas A; Keller A; Menoux I; Brahimi Y; Vigneron C; Le Fèvre C; Chambrelant I; Pietta GA; Guihard S; Clavier JB; Antoni D; Noël G
    Cancer Radiother; 2022 Sep; 26(5):684-691. PubMed ID: 35227594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of acute skin toxicity in breast radiotherapy with a new quantitative approach.
    González Sanchis A; Brualla González L; Sánchez Carazo JL; Gordo Partearroyo JC; Esteve Martínez A; Vicedo González A; López Torrecilla JL
    Radiother Oncol; 2017 Jan; 122(1):54-59. PubMed ID: 27825796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated radiation therapy for early stage breast cancer: outcomes, toxicities, and cost analysis.
    Min C; Connolly E; Chen T; Jozsef G; Formenti SC
    Breast J; 2014; 20(3):267-73. PubMed ID: 24750510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial.
    Krug D; Baumann R; Krockenberger K; Vonthein R; Schreiber A; Boicev A; Würschmidt F; Weinstrauch E; Eilf K; Andreas P; Höller U; Dinges S; Piefel K; Zimmer J; Dellas K; Dunst J
    Strahlenther Onkol; 2021 Jan; 197(1):48-55. PubMed ID: 33001241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-weekly hypofractionated radiotherapy for breast cancer: First results of a phase II clinical trial.
    Reboucas LM; Campos CS; D'Amico GM; Lustosa AB; Fregnani JH
    Breast J; 2019 Sep; 25(5):953-957. PubMed ID: 31165541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute radiodermatitis in modern adjuvant 3D conformal radiotherapy for breast cancer - the impact of dose distribution and patient related factors.
    Borm KJ; Loos M; Oechsner M; Mayinger MC; Paepke D; Kiechle MB; Combs SE; Duma MN
    Radiat Oncol; 2018 Nov; 13(1):218. PubMed ID: 30404664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic beclomethasone spray to the skin during postoperative radiotherapy of carcinoma breast: a prospective randomized study.
    Shukla PN; Gairola M; Mohanti BK; Rath GK
    Indian J Cancer; 2006; 43(4):180-4. PubMed ID: 17192690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of patient-rated measures of radiodermatitis in breast cancer radiotherapy.
    Schnur JB; Love B; Scheckner BL; Green S; Wernicke AG; Montgomery GH
    Am J Clin Oncol; 2011 Oct; 34(5):529-36. PubMed ID: 20838323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-induced Skin Toxicity in Breast Cancer Patients: A Systematic Review of Randomized Trials.
    Yee C; Wang K; Asthana R; Drost L; Lam H; Lee J; Vesprini D; Leung E; DeAngelis C; Chow E
    Clin Breast Cancer; 2018 Oct; 18(5):e825-e840. PubMed ID: 30072193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant suppression of radiation dermatitis in breast cancer patients using a topically applied adrenergic vasoconstrictor.
    Cleary JF; Anderson BM; Eickhoff JC; Khuntia D; Fahl WE
    Radiat Oncol; 2017 Dec; 12(1):201. PubMed ID: 29273054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Radiodermatitis on Breast Cancer Patients' Quality of Life During Radiotherapy: A Prospective Cohort Study.
    Fuzissaki MA; Paiva CE; Oliveira MA; Lajolo Canto PP; Paiva Maia YC
    J Pain Symptom Manage; 2019 Jul; 58(1):92-99.e1. PubMed ID: 30974233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the quality of life of women undergoing radiotherapy.
    Vilhena FDM; Pereira OV; Sousa FJD; Martins NCN; Albuquerque GPX; Lopes RGBDS; Sagica TDP; Ramos AMPC
    Rev Gaucha Enferm; 2024; 45():e20230062. PubMed ID: 38359280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique hypofractionated radiotherapy schedule with 51.3 Gy in 18 fractions three times per week for early breast cancer: outcomes including local control, acute and late skin toxicity.
    Vassilis K; Ioannis G; Anna Z; Christina A; Christos A; John K; Porfyrios K; Vassiliki G; John K
    Breast Cancer; 2017 Mar; 24(2):263-270. PubMed ID: 27093861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.